Arzerra Injection
Prescription Required
Product introduction
Arzerra Injection is used in the treatment of blood cancer (chronic lymphocytic leukemia). It binds to receptors on cancer cells. Thus it flags the cancer cells for destruction by the body's immune system.
Arzerra Injection is used in the treatment of a wide variety of diseases including certain types of cancers and autoimmune diseases. This medicine destroys a type of white blood cell, called the B-cell, that has a role in the body's immune system. This injection is given by a doctor or nurse in a hospital or an outpatient clinic.
Arzerra Injection is used in the treatment of a wide variety of diseases including certain types of cancers and autoimmune diseases. This medicine destroys a type of white blood cell, called the B-cell, that has a role in the body's immune system. This injection is given by a doctor or nurse in a hospital or an outpatient clinic.
Uses of Arzerra Injection
Benefits of Arzerra Injection
In Blood cancer (Chronic lymphocytic leukemia)
Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Arzerra Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but you should discuss the side effects and benefits of this medicine with your doctor. Let your doctor know if any of the side effects bothers you.
Side effects of Arzerra Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Arzerra
- Nausea
- Diarrhea
- Breathlessness
- Cough
- Flushing of skin
- Low energy
- Skin rash
How to use Arzerra Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Arzerra Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Arzerra Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Arzerra Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Arzerra Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
SAFE IF PRESCRIBED
Arzerra Injection is safe to use in patients with kidney disease. No dose adjustment of Arzerra Injection is recommended.
Liver
UNSAFE
Arzerra Injection is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Arzerra Injection is given as an IV infusion under the supervision of a doctor.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- Your doctor may get regular blood tests done to monitor your blood cell count (CBC), liver and kidney function.
- Inform your doctor if you experience fever, chills, rash, dizziness and shortness of breath during the treatment.
Fact Box
Chemical Class
Monoclonal antibody (mAb)
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
CD 20 Inhibitor
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmanβs: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1747-48.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1011.
- Ofatumumab. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2009 [revised Jan. 2016]. [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: Glaxo SmithKline Pharmaceuticals Ltd
Address: Dr. Annie Besant Road, Mumbai - 400 030
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
βΉ50556
Inclusive of all taxes
3.0 injections in 1 vial
SOLD OUT